BPC January 10 update

Molecular MOLN NVO Phase 2 data; Century IPSC BMY Deal

Pre-Market Updates

Molecular Partners AG (NASDAQ: MOLN) and Novartis (NYSE: NVO) announced that Part A of their EMPATHY Phase 2 trial of ensovibep to treat COVID-19, met the primary endpoint. Novartis will exercise its option to in-license ensovibep, and Molecular Partners will receive a milestone payment of 150 million CHF and be entitled to a 22% royalty on sales.

Century Therapeutics (NASDAQ: IPSC) and Bristol Myers Squibb (NYSE: BMY) announced an agreement to develop and commercialize up to four induced pluripotent stem cell-derived, engineered natural killer cells and/or T cell programs for hematologic malignancies and solid tumors. Century Therapeutics will receive $150 million in cash with the potential for an additional $3 billion in milestone payments plus royalties.

Pluristem Therapeutics Inc (NASDAQ: PSTI) and Tnuva Group have collaborated to develop cultured cell-based products for the food industry. The collaboration started with the incorporation of a new company that will receive exclusive licensing rights to use Pluristem's proprietary technology in the field of cultured meat.

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) announced that the FDA notified it that it may proceed with Phase 3 trial of brilaroxazine to treat schizophrenia.

Agile Therapeutics, Inc. (NASDAQ: AGRX) announced a new alliance with Afaxys Pharma, LLC to promote the Twirla (levonorgestrel and ethinyl estradiol) transdermal system.

Pre-Market Advancers

CompanyPriceChange
CGTX
Cognition Therapeutics Inc.
$4.30+0.8  +22.86%
HOOK
HOOKIPA Pharma Inc.
$1.79+0.29  +19.33%
MRKR
Marker Therapeutics Inc.
$0.71+0.11  +18.33%
IMMX
Immix Biopharma Inc.
$5.31+0.8  +17.74%
BSGM
BioSig Technologies Inc.
$2.10+0.3  +16.67%
CALA
Calithera Biosciences Inc.
$0.52+0.0678  +14.99%
PALI
Palisade Bio Inc.
$1.21+0.155  +14.69%
RMTI
Rockwell Medical Inc.
$0.45+0.0568  +14.45%
VRPX
Virpax Pharmaceuticals Inc.
$2.63+0.3301  +14.35%
NRBO
NeuroBo Pharmaceuticals Inc.
$1.28+0.16  +14.29%

Pre-Market Decliners

CompanyPriceChange
ARDS
Aridis Pharmaceuticals Inc.
$1.32-0.28  -17.50%
HILS
Hillstream BioPharma Inc.
$2.89-0.47  -13.99%
CINC
CinCor Pharma Inc.
$15.66-2.54  -13.96%
RUBY
Rubius Therapeutics Inc.
$6.54-0.7615  -10.43%
GMDA
Gamida Cell Ltd.
$2.95-0.29  -8.95%
KPTI
Karyopharm Therapeutics Inc.
$7.63-0.65  -7.85%
BDSI
BioDelivery Sciences International Inc.
$3.10-0.26  -7.74%
ITCI
Intra-Cellular Therapies Inc.
$39.57-3.09  -7.24%
BNTC
Benitec Biopharma Inc.
$2.31-0.18  -7.23%
VAXX
Vaxxinity Inc.
$7.57-0.59  -7.23%